1. [P4–031]: ALZHEIMER'S DISEASE AS A DISORDER OF TRYPTOPHAN METABOLISM. (1st July 2017) Authors: Weaver, Donald F.; Meek, Autumn; Barden, Christopher; Reed, Mark; Taylor, Marcia; Wang, Yanfei; Brant, Michael; Stafford, Paul; Kelly, Brendan; Diez, Elena Cecilia Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 26 Page Start: P1267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Amyloid‐beta is a cytokine. (1st February 2022) Authors: Weaver, Donald F; Meek, Autumn Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Amyloid‐beta is a cytokine. (December 2021) Authors: Weaver, Donald F; Meek, Autumn Journal: Alzheimer's & dementia Issue: Volume 17(2021)Supplement 3 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Drug–Receptor Interactions: It is a Numbers Game. (29th July 2022) Authors: Meek, Autumn; Weaver, Donald F. Journal: Canadian journal of neurological sciences Issue: Volume 49:Number 4(2022) Page Start: 589 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Ferulic acid amide derivatives with varying inhibition of amyloid-β oligomerization and fibrillization. (1st August 2021) Authors: Kolaj, Igri; Wang, Yanfei; Ye, Kailin; Meek, Autumn; Liyanage, S. Imindu; Santos, Clarissa; Weaver, Donald F. Journal: Bioorganic & medicinal chemistry Issue: Volume 43(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P2‐044: The Development of High Throughput Screening Strategies to Identify Anti‐Proteopathic and Anti‐Immunopathic Agents for The Treatment of Alzheimer's Dementia. (1st July 2016) Authors: Weaver, Donald F.; Meek, Autumn; Barden, Christopher; Reed, Mark; Taylor, Marcia; Wang, Yanfei; Simms, Gordon A. Journal: Alzheimer's & dementia Issue: Volume 12:Supplement 7S(2016)Part 13 Page Start: P624 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P4‐169: Identification of endogenous β‐amyloid anti‐oligomerization agents via in silico screening of a library of known human cns compounds against the e‐v‐h‐h‐q‐k domain of β‐amyloid. (1st July 2015) Authors: Meek, Autumn; Simms, Gordon A.; Wang, Yanfei; Wu, Fan; Taylor, Marcy; Reed, Mark; Barden, Christopher; Weaver, Donald F. Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 18 Page Start: P843 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P4‐220: DEVELOPMENT OF TRYPTOPHAN‐BASED BETA‐AMYLOID ANTI‐AGGREGANTS. (1st July 2014) Authors: Weaver, Donald F.; Kelly, Brendan; Diez, Elena Cecilia; Pan, Luzhe; Wang, Yanfei; Simms, Gordon; Meek, Autumn; Hawco, Cassandra; Taylor, Marcy; Reed, Mark; Barden, Christopher Journal: Alzheimer's & dementia Issue: Volume 10:Supplement 4S(2014)Part 23 Page Start: P868 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. The in silico search for endogenous anti‐Alzheimer's compounds: Nonhuman/Novel screening strategies. (7th December 2020) Authors: Weaver, Donald F; Barden, Christopher; Gupta, Mayuri; Meek, Autumn; Reed, Mark; Wang, Yanfei; Wu, Fan Journal: Alzheimer's & dementia Issue: Volume 16(2020)Supplement 9 Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗